FDA

FDA Approves Boxed Warning on Xeljanz (Tofacitinib)

FDA Approves Boxed Warning on Xeljanz (Tofacitinib)

The US Food and Drug Administration approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis.

This new warning, issued July 26, 2019, comes just a few months after the first warning issued February 25, 2019.

Read More


Blood Pressure Medication Recall Expanded

Blood Pressure Medication Recall Expanded

Torrent Pharmaceuticals is recalling an additional 36 lots of Losartan potassium tablets and 68 lots Losartan potassium/hydrochlorothiazide tablets. This is the fourth expansion of the original recall posted in December 2018 of blood pressure medications manufactured by the company.

Read More


FDA Orders Two to Stop Selling Pelvic Mesh, Citing Safety Concerns

FDA Orders Two to Stop Selling Pelvic Mesh, Citing Safety Concerns

Surgical mesh has been used to treat hernias since the 1950s. In the 1970s, gynecologists began using it for abdominal repair of pelvic organ prolapse (POP) and in the 1990s for the transvaginal repair of POP.

Read More


FDA’s Hidden Reports on Medical Devices

FDA’s Hidden Reports on Medical Devices

March 8, 2019. In an article published by Kaiser Health News, we learned that some medical device manufacturers have been using a secret reporting mechanism to let the FDA know of problems with their devices.

The problem? The data is hidden so that neither the public nor doctors are aware of any problems reported.

Read More


Essure Device: FDA Safety Oversight after Discontinuation of US Sales

Essure Device: FDA Safety Oversight after Discontinuation of US Sales

December 20, 2018. FDA Commissioner, Scott Gottlieb, issued a statement on the new steps the FDA will take to strengthen the long-term safety oversight of Essure.  In his statement, Gottlieb said the FDA will continue to evaluate the product’s long-term safety profile even after it has been discontinued in the US market.

Read More


FDA to Overhaul Medical Device Review System

FDA to Overhaul Medical Device Review System

“Forty-two years ago, Congress passed the law establishing the framework for evaluating the safety and effectiveness of medical devices.”

On Monday, November 26, 2018, the Food and Drug Administration announced that it plans to modernize its current process, the 510(k) clearance pathway, which is how a majority of the medical devices are reviewed and approved by the FDA today.

Read More


Zimmer Biomet Receives FDA Warning Letter

Zimmer Biomet Receives FDA Warning Letter

On August 24, 2018, Zimmer Biomet received a Warning Letter from the FDA regarding quality violations found during 2016 and 2018 inspections at a facility in Warsaw, IN.

Read More


Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Devices

Magnetic Resonance-guided Laser Interstitial Thermal Therapy (MRgLITT) Devices

FDA Letter to Health Care Providers

Posted by the FDA on April 25, 2018.

The Issue: FDA is providing preliminary information concerning magnetic resonance (MR) thermometry reliability with magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) devices.

Read More


FDA Restrictions Placed on Essure

FDA Restrictions Placed on Essure

Permanent birth control is one of the most widely used methods of contraception today. It can be highly effective, doesn’t require a surgical procedure and women no longer have to remember to take a daily pill. So why has the FDA restricted the sale and distribution of the Essure device and required boxed warnings?

Read More


FDA 510(k) – aka, Substantially Equivalent

FDA 510(k) – aka, Substantially Equivalent

Products such as new drugs and complex medical devices must be proven safe and effective before companies can put them on the market.

Read More


Contact Us Today for Help!